The present invention relates to a medical implant for cartilage and/or bone repair at an articulating surface of a joint. The implant comprises a contoured implant body and at least one extending post. The implant body has an articulating surface configured to face the articulating part of the joint and a bone contact surface configured to face the bone structure of a joint, where the said articulating and bone contact surfaces face mutually opposite directions and said bone contact surface is provided with the extending post. A cartilage contact surface connects the articulating and the bone contact surfaces and is configured to contact the cartilage surrounding the implant body in a joint. The articulating surface has a layer that consists of titanium nitride (TiN) as the wear-resistant material. The cartilage contact surface has a coating that substantially consists of a material having chondrointegration properties.

A method for controlling generation of biologically desirable voids in a composition placed in proximity to bone or other tissue in a patient by selecting at least one water-soluble inorganic material having a desired particle size and solubility, and mixing the water-soluble inorganic material with at least one poorly-water-soluble or biodegradable matrix material. The matrix material, after it is mixed with the water-soluble inorganic material, is placed into the patient in proximity to tissue so that the water-soluble inorganic material dissolves at a predetermined rate to generate biologically desirable voids in the matrix material into which bone or other tissue can then grow.

An implant having a unitary body includes an intramedullary portion and an extramedullary portion. The intramedullary portion is sized and structured to be received within an intramedullary canal of a first bone and defines a longitudinal axis. The extramedullary portion includes a surface defining an axis that is disposed at an angle with respect to the longitudinal axis. An aperture defined along the extramedullary portion is sized and configured to receive a fastener therein for coupling the extramedullary portion of the implant to a second bone.

A medical implant for cartilage and/or bone repair at an articulating surface of a joint is provided. The implant includes a contoured implant body and at least one extending post. The implant body has an articulating surface configured to face the articulating part of the joint and a bone contact surface configured to face the bone structure of a joint, where the articulating and bone contact surfaces face mutually opposite directions and the bone contact surface is provided with the extending post. A cartilage contact surface connects the articulating and the bone contact surfaces and is configured to contact the cartilage surrounding the implant body in a joint. The articulating surface has a layer that is formed of titanium nitride (TiN) as the wear-resistant material. The cartilage contact surface has a coating that is formed of a material having chondrointegration properties.

Endosseous implant to be applied to a human or animal bone, wherein the surface of the implant is made from titanium or a titanium alloy, said implant having a smooth or rough surface texture, which is characterized in that said surface has been treated with at least one selected organic phosphonate compound or a pharmaceutically acceptable salt or ester or an amide thereof; process for producing said implants.

The invention relates to a knee joint prosthesis comprising a femoral component (1) and a tibial component (2), each having a front face constituting the joint and a rear face (4) facing the bone, and a polyethylene (PE) liner (3). In order to allow the knee joint prosthesis to be implanted without metal and without cement, the femoral component (1) and the tibial component (2) consist of a full ceramic material and both components (1, 2) have integrated porous osseointegrative rear faces (4) facing the bone.

An implant having a unitary body includes an intramedullary portion and an extramedullary portion. The intramedullary portion is sized and structured to be received within an intramedullary canal of a first bone and defines a longitudinal axis. The extramedullary portion includes a surface defining an axis that is disposed at an angle with respect to the longitudinal axis. An aperture defined along the extramedullary portion is sized and configured to receive a fastener therein for coupling the extramedullary portion of the implant to a second bone.

Provided herein is an implant made of a biocompatible ceramic of synthetic origin obtained by additive manufacturing. The implant may include a dense portion featuring a material density by volume greater than 70%, and a porous portion connected to the dense portion by a connection zone. The porous portion may have an average macroporosity having a material density ranging from 30% to 70% by volume and cavities defining cavity sections, with a diameter ranging from 0.3 mm to 1.2 mm. The dense portion and the porous portion may define an external surface. The cavities may open onto the external surface.

A prosthesis for a synovial joint arthroplasty within a human body is provided. The prosthesis includes a first prosthetic component, the first prosthetic component including a first surface and the first prosthetic component being formed of a copolymer elastomer compound, the copolymer elastomer compound including a thermoplastic elastomer, a plurality of long glass fibers, the long glass fibers being randomly dispersed throughout the thermoplastic elastomer to improve surface fatigue life and inhibit surface crack propagation to the prosthesis and improve wear resistance of the prosthesis, a number of the plurality of long glass fibers protruding outward from the first surface of the first prosthetic component; a second prosthetic component, the second prosthetic component including a second surface, the second surface of the second prosthetic component positioned proximate the first surface of the first prosthetic component to engage the plurality of long glass fibers protruding from the first surface of the first prosthetic component allowing the second surface of the second prosthetic component to slide relative to the first surface of first prosthetic component while contacting the plurality of long glass fibers protruding outward from the first surface of the first prosthetic component, a gap, the gap created by the voids between the second surface of the second prosthetic component, the first surface of the first prosthetic component and the plurality of long glass fibers that protrude outward from the first surface of the first prosthetic component, the gap further disposed between the first surface of the first prosthetic component and the second surface of the second prosthetic component to allow the passage of fluid between the first surface of the first prosthetic component and the second surface of the second prosthetic component, a first trough, the first trough formed as the plurality of long glass fibers protruding outward from the first surface are forced into the thermoplastic elastomer as the prosthesis is loaded, the first trough positioned proximate each of the plurality of long glass fibers and encasing a perimeter of each of the plurality of long glass fibers.

A method for controlling generation of biologically desirable voids in a composition placed in proximity to bone or other tissue in a patient by selecting at least one water-soluble inorganic material having a desired particle size and solubility, and mixing the water-soluble inorganic material with at least one poorly-water-soluble or biodegradable matrix material. The matrix material, after it is mixed with the water-soluble inorganic material, is placed into the patient in proximity to tissue so that the water-soluble inorganic material dissolves at a predetermined rate to generate biologically desirable voids in the matrix material into which bone or other tissue can then grow.